InvestorsHub Logo
Followers 54
Posts 4488
Boards Moderated 0
Alias Born 04/18/2009

Re: None

Friday, 10/13/2017 6:32:37 AM

Friday, October 13, 2017 6:32:37 AM

Post# of 1407
Headed back to $4 within a matter of days. This was a huge overreaction to a temporary setback. Approval of the drug appears to be within reach. The FDA simply requires re-submission with a few changes. From the PR, "We believe the recommendations stated in the CRL are manageable and plan to fully cooperate with the FDA."

The content of my messages are my own opinions and sentiments at the time of posting. My thoughts on a stock may change as new facts and conditions present themselves. No one should base their investing on my opinions. Do your own research and decide i

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TLPH News